The Global Next Generation Immunotherapies Industry is on track for a significant expansion, driven by a growing emphasis on personalized and effective cancer treatment options. According to a recent analysis by Future Market Insights (FMI), the market is expected to reach a staggering valuation of over US$268.84 billion by 2033. This remarkable growth trajectory is …